𝔖 Bobbio Scriptorium

✦ LIBER ✦

Effect of acute and chronic treatment with QCF-3 (4-benzylpiperazin-1-yl) (quinoxalin-2-yl) methanone, a novel 5-HT3 receptor antagonist, in animal models of depression

✍ Scribed by Devadoss, Thangaraj; Pandey, Dilip K.; Mahesh, Radhakrishnan; Yadav, Shushil K.

Book ID: 122292029
Publisher: Elsevier
Year: 2010
Tongue: English
Weight: 432 KB
Volume: 62
Category: Article
ISSN: 1734-1140
DOI: 10.1016/S1734-1140(10)70263-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characterisation of the selective 5-HT1B

Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2′-methyl-4′-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): In vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity

✍ Lee A. Dawson; Zoë A. Hughes; Kathryn R. Starr; James D. Storey; Letizia Betteli 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 423 KB

Antidepressant and anti-anxiety like eff

Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models

✍ Gupta, Deepali; Radhakrishnan, Mahesh; Thangaraj, Devadoss; Kurhe, Yeshwant 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 540 KB